Авторы: доктор медицинских наук, профессор В.Ф. Беженарь академик РАН, доктор медицинских наук, профессор Э.К. Айламазян доктор медицинских наук, профессор И.Е. Зазерская доктор медицинских наук, профессор Д.О. Иванов доктор медицинских наук, профессор Б.В. Аракелян доктор медицинских наук, доцент А.Е. Баутин ассистент О.А. Беттихер кандидат медицинских наук Г.В. Гриненко кандидат медицинских наук Ю.В. Долго-Сабурова кандидат медицинских наук К.А. Загородникова доктор медицинских наук, профессор М.С. Зайнулина кандидат медицинских наук, доцент А.Б. Ильин кандидат медицинских наук М.Ф. Ипполитова кандидат медицинских наук, доцент А.Н. Кучерявенко доктор медицинских наук, профессор В.А. Мазурок кандидат медицинских наук И.М. Нестеров доктор медицинских наук, профессор В.А. Шапкайц Рецензенты: Дмитрий Анатольевич Лиознов-доктор медицинских наук, профессор, исполняющий обязанности директора ФГБУ «Научно-исследовательский институт гриппа им. А.А. Сморо динцева» Министерства здравоохранения РФ; заведующий кафедрой инфекционных болезней и эпидемиологии ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Министерства здравоохранения Российской Федерации Алексей Валерьянович Щеголев-доктор медицинских наук, профессор, полковник медицинской службы, начальник кафедры военной анестезиологии и реаниматологии ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» Министерства обороны Российской Федерации, главный анестезиолог-реаниматолог Министерства обороны Российской Федерации Николай Николаевич Рухляда-доктор медицинских наук, профессор заведующий кафедрой акушерства и гинекологии ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Министерства здравоохранения Российской Федерации Андрей Александрович Шмидт-кандидат медицинских наук, доцент, полковник медицинской службы, начальник кафедры акушерства и гинекологии ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» Министерства обороны Российской Федерации, главный акушергинеколог Министерства обороны Российской Федерации К49 Краткие клинические рекомендации. Тактика ведения беременных, рожениц и родильниц с подозрением или подтвержденной инфекцией COVID-19.
An integrated approach to maintaining reproductive health includes, among other things, primary prevention of cervical cancer and other diseases associated with the human papillomavirus. Girls 11-14 years old vaccination against human papillomavirus is a priority in the fight against HPV-associated diseases. The purpose of the work is to show the methodology of legal support for the formation and implementation of the HPV vaccine prevention program, which is not included in the National Vaccination Calendar, using the example of the system, institutions and services aimed at protecting the reproductive health of children and adolescents in St. Petersburg. Materials and methods. Primary specific prophylaxis of HPV-associated diseases was carried out by certified vaccines: bivalentfor protection against HPV types 16 and 18, and tetravalent-for types 6, 11, 16, 18. Information on vaccination was included in the certificate of preventive vaccinations, form No. 156/у-93 A6. Determining the size of contingents to be vaccinated, taking into account the prevalence of infectious diseases was carried out according to the statistical forms: No. 30 «Information about the medical organization», No. 2 «Information about infectious and parasitic diseases», No. 5 «Information about preventive vaccinations». Results. From 2012 to 2014, 22,548 girls between the ages of 12 and 14 years of age (13% of the subject) were covered by vaccination; from 2015 to 2018, 13,062 girls (7.5% of the subject) were covered. First of all, girls who are on full state support and are at risk (from families with an oncologic history) were vaccinated. From 2015, young woman under 17 years old began to be vaccinated. The planned coverage in 2019 will be 9.2% of the population to be immunized. All vaccinated were patients of children's city polyclinics. Conclusion. The world practice of using vaccination against oncogenic viruses has proven its effectiveness against human papillomavirus infection. Before deciding on the inclusion of vaccines against HPV infection in the National Schedule of Vaccines, the health authorities of the constituent entities of the Russian Federation should actively look for opportunities to form and implement regional vaccination programs. We have shown one of the possible ways. The current favorable conditions for the development of maternal and child health services contribute to the inclusion of vaccination against HPV infection in the immunization schedules of the constituent entities of the Russian Federation.
Санкт-Петербургское государственное бюджетное учреждение здравоохранения «Городской консультативно-диагностический центр для детей "Ювента" (репродуктивное здоровье)», 190020, г. Санкт-Петербург, Российская Федерация Физиология и психология взросления 66 Репродуктивное здоровье детей и подростков / Том 17. № 2, 2021
Development and preservation of reproductive potential is the actual practical direction of national health care. There are presented results of the medical examination of the child population of St. Petersburg, there are noted gender-age features of somatic, urological and gynecological pathology in adolescents. The effectiveness of medical and social system of the care of adolescent reproductive health was established to manifest by the increased their interest and demand for special consultative structures, the decrease in the number of abortions and sexually transmitted infections. Primary health care activities of youth consultation specialists in conjunction with the teaching teams on moral and sexual education and shaping of healthy lifestyle provide the reduction in the level of risk sexual behavior of adolescents and the improvement of their medical activity. There was shown the necessity of the further improvement of the system of medical and social care for adolescents for the prevention of unwanted pregnancies, sexually transmitted diseases, bad habits and shaping of healthy lifestyle skills.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.